Month: April 2021

Categories
Entertainment

Shock G, Frontman for Hip-Hop Group Digital Underground, Dies at 57

Shock G, Frontman for Hip-Hop Group Digital Underground, Dies at 57

When it was Mr. Shakur’s turn he quickly released a thoughtful verse about the dangers of success: “Get some fame, people change.”

Mr. Shakur had auditioned for Shock G and was hired as a member of the group’s street crew. He ended up performing and recording with Digital Underground. He appeared in the groups “This Is an EP Release” (Tommy Boy) and “Sons of the P” (Tommy Boy), which were nominated for a Grammy Award.

In 1991, Mr. Shakur started a solo career with the album “2Pacalypse Now” (Interscope), which sold half a million times. It included two humble hits, “Trapped” and “Brenda’s Got a Baby,” a song about the plight of an unmarried teenage mother. Before the album was released, he also began a career as a film actor, playing the violent, unpredictable bishop in the Ernest Dickerson film “Juice”.

Until 1993, Mr. Shakur was a rising star. Shock G and another member of the Digital Underground, Money B, appeared on Mr. Shakur’s album and helped create his first big hit, “I Get Around,” a poolside hymn with a relaxed beat. But now it was Shock G with an Afro T-shirt and an oversized purple T-shirt that said, “Now you can tell from my everyday seizures that I’m not rich man caught in the mix / Tryna makes 15 cents one dollar. “

Shock G was born in Brooklyn on August 25, 1963, and his musical instincts were shaped by a childhood spent moving around the country. His mother, Shirley Kraft, was a television producer; his father, Edward Racker, was a senior executive in computer administration. After the couple divorced, “I spent most of my time in Tampa, but I also lived in New York, Philly, and California,” Shock G told the Times. “I was always interested in music and played in bands when I was 10 or 11 years old.”

His grandmother, Gloria Ali, was a pianist and cabaret singer in Harlem in the 1950s. She taught him how to play Thelonious Monk’s “Round Midnight” on the piano. When hip-hop picked up speed in New York in the late 1970s, Shock G, who lived there at the time, recalled: “All my friends and I sold our instruments to buy mixers and turntables.”

Shock G is survived by his parents; his sister Elizabeth Racker; and his brother Kent Racker.

Shock G saw music as expansive, inclusive, and experimental. “Funk can be rock, funk can be jazz and funk can be soul,” he told the Times. “Most people have a checklist of what makes a good pop song: It has to be three minutes long, have a repeatable chorus, and have a catchy catch. That makes music stale. We say, “Do what feels good.” If you like it for three minutes, you will love it for 30 minutes. “

Christina Morales and Jesus Jiménez contributed to the coverage.

Categories
Health

U.S. could by no means attain ‘true herd immunity,’ says Dr. Scott Gottlieb

U.S. may never reach 'true herd immunity,' says Dr. Scott Gottlieb

Dr. Scott Gottlieb told CNBC on Friday he believes the United States may struggle to achieve “true herd immunity” to Covid, suggesting there will be coronavirus infections in the years to come.

However, the former commissioner of the U.S. Food and Drug Administration stressed that new cases alone should not be the metric that gets the greatest focus as more people are vaccinated against Covid.

“I don’t think we should think about achieving herd immunity. I don’t know that we will ever achieve real herd immunity where this virus simply no longer circulates,” said Gottlieb at “Closing Bell”. “I think it will always be circulating at low levels. That should be the goal of keeping virus levels down.”

Gottlieb, who serves on the board of directors at Covid vaccine maker Pfizer, expects the US to make significant strides toward that goal in the coming weeks.

“I think we’ll reach a point this summer where the spread of this virus will be extremely low. We’ll likely see the cases collapse pretty soon sometime in May. We’re already seeing it in parts of the country.” said Gottlieb.

Even so, according to Gottlieb, the US could flatten about 5,000 to 10,000 new coronavirus cases per day this summer, partly due to how commonplace Covid testing has become. “We’re going to see a lot of asymptomatic and mildly symptomatic infections,” he said.

“I think the bottom line is that vaccination is dramatically reducing the susceptibility of the American population, and that’s what we really need to focus on,” said Gottlieb, who headed the FDA in the Trump administration from 2017 to 2019.

“We shouldn’t just focus on cases. There will be cases, but we should focus on how many people are hospitalized and get this virus. That will drop dramatically when we introduce the vaccines,” he said.

Public health experts have stressed throughout the pandemic that the more people in a population have immunity protection for a particular virus, the less easily it will spread. While vaccines have been shown to reduce transmission, Gottlieb isn’t the first to point out that achieving permanent herd immunity is likely to be a challenge for Covid.

The Chief Medical Officer of the White House, Dr. Anthony Fauci, has estimated that 75% to 85% of the population vaccinated against Covid would create an “umbrella” of immunity. “That could even protect the vulnerabilities that weren’t vaccinated or where the vaccine wasn’t effective,” he told CNBC in December, shortly after the FDA approved Pfizer’s emergency use of Pfizer.

About 41% of the US population have now received at least one dose of Covid vaccine, and 27.5% are fully vaccinated, according to the latest information from the Centers for Disease Control and Prevention. CDC data show that a total of more than 220 million doses were administered.

Gottlieb previously said that the US could theoretically get to a point where Covid, like other diseases like polio and smallpox, will be eradicated. “It is possible. We do not seem ready to do this and take the collective action that is required,” he told CNBC on April 16.

“It will take people who practice a civic virtue to get vaccinated, even if they individually feel low risk of infection,” he said. “Because even if they are at low risk, they can still get and transmit the infection, and you cannot eradicate a disease where you have a significant contingent of people who will continue to catch and transmit it.”

Disclosure: Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, genetic testing startup Tempus, health technology company Aetion Inc., and biotech company Illumina. He is also co-chair of Norwegian Cruise Line Holdings and Royal Caribbean’s Healthy Sail Panel.

Categories
Business

We are able to vaccinate our method out of this epidemic if all adults get photographs, says physician

J&J asked Pfizer, Moderna to help study blood clots but they declined: WSJ

Daylight saving time in the United States could return to pre-Covid-19 normal if 75% to 80% of the US population are vaccinated, said Dr. Peter Hotez on Friday.

“We can vaccinate out of this epidemic if all adults and adolescents are vaccinated by summer. We can have an exceptional quality of life by returning to concerts and music events, as well as ball games, bars, restaurants, clubs and clubs.” all the things we like to do so we have to work towards them, “said Hotez.

Hotez, co-director of the vaccine development center at Texas Children’s Hospital, told CNBC’s The News with Shepard Smith that vaccine hesitation will prevent the US from getting 75% to 80% of the population vaccinated.

The demand for the Covid-19 vaccine has fallen in all states. Louisiana, for example, asked for fewer cans because the demand was so low. Polls show that more than 40% of Republicans do not plan to vaccinate, and Hotez advised health professionals to reach out to conservative groups to help protect the entire US population.

“About 40% to 45% of Republicans say they may not or may not take the vaccine, and when you add the numbers that’s about 10% of the adult population,” Hotez said. “There we have to work harder to reach conservative groups … that we have to fix.”

Categories
Politics

Biden to go to Belgium, UK in first abroad journey as president

Biden to visit Belgium, UK in first overseas trip as president

President Joe Biden waves as he boards Air Force One before leaving Andrews Air Force Base, Maryland on February 5, 2021.

Almond Ngan | AFP | Getty Images

President Joe Biden will make his first overseas tour as President in June when he visits the UK and Belgium for important meetings with allied nations, the White House said Friday.

This news comes amid Biden’s virtual climate summit with world leaders as he advocates reducing greenhouse gas emissions. On Thursday, Biden pledged to cut US emissions by at least 50% by 2030.

The Biden administration has announced that it will reset ties with various allies after President Donald Trump’s often turbulent relations with other nations. Trump criticized other NATO nations, saying they were not paying their fair share of defense spending.

Biden will begin his journey at the G7 summit in Cornwall, UK, where he will also hold bilateral meetings with leaders such as UK Prime Minister Boris Johnson. This summit will take place from June 11th to 13th.

CNBC policy

Read more about CNBC’s political coverage:

The president will work to “advance major US political priorities on public health, economic recovery and climate change, and to demonstrate solidarity and shared values ​​among major democracies,” the White House statement said.

Biden will then travel to Brussels to attend NATO and US-EU meetings, where he will continue to advance American interests. The NATO meeting is scheduled for June 14th.

One topic for the NATO discussion could be the recent escalation of the Russian troop presence on the border with Ukraine to its highest level since 2014. However, Russia on Thursday ordered these troops to return to their home bases after a so-called “rapid inspection”.

Another possible point of discussion could be the withdrawal of NATO forces from Afghanistan, where the alliance’s non-combat Resolute Support Mission has been helping Afghan troops since 2015.

White House press secretary Jen Psaki said more details about Biden’s trip would come, “including potential additional items”.

Categories
Business

Murdoch’s Decide to Run The New York Put up Bets On the Internet and Celebs

Murdoch’s Pick to Run The New York Post Bets On the Web and Celebs

Rupert Murdoch took a top editor from his cheeky and conservative London tabloid The Sun and hired him to run his bold and conservative New York tabloid, The New York Post.

Keith Poole, a 44-year-old Englishman who has redesigned The Sun’s website for the past few years, started as the Post’s editor-in-chief on March 22. Most employees have not heard from him since then, said two Post employees.

He had lunch with Emily Smith, longtime editor of The Post’s Gossip franchise, but had yet to make an all-hands video call to greet the employees who were working remotely or an email greeting two people said and spoke on condition of anonymity to uncover internal matters. For some employees, the only evidence of the new boss’s presence was the addition of his name to the main newsroom channel on Slack, the messaging app.

A spokeswoman for The Post said in an email that Mr. Poole would get to know the team in his own way: “Keith has met a number of Post employees in person, via video call and over the phone (as most of them work from there) home), and he’s had lunch with other coworkers, not just Emily. “

Mr. Poole effectively replaced Col Allan, an Australian tabloid specialist who retired in March after more than 40 years with Murdoch Papers.

Mr. Poole has more experience attracting online readers than his predecessor. Before joining The Sun as a digital editor in 2016, he helped make The Daily Mail’s U.S. website a must-have for fans of celebrity gossip.

“At The Sun, it’s all you focus on,” said Chris Spargo, a reporter who worked for both of Mr. Poole’s previous employers. Mr Poole also sees The Daily Mail as the Post’s main competitor, said several people with knowledge of the Post’s newsroom.

In business today

Updated

April 23, 2021 at 1:31 p.m. ET

A former colleague said Mr. Poole did not fit the stereotype of the gruff, boisterous tabloid editor.

“Keith is charming and has that British joke,” said David Martosko, former US political editor at The Daily Mail who is now Senior Content Executive at Zenger News. “More people in our business should adopt his collaborative editing style.”

His responsibilities include not only the now profitable New York tabloid, which Mr. Murdoch took out of bankruptcy in the 1990s, but also the larger New York Post Group. These include the Post Digital Network, which consists of the newspaper’s website, a separate website for page 6, the entertainment website Decider.com, and the advertising agency Post Studios.

Mr. Poole, who studied at Loughborough University in England, came to New York after most postal workers had worked from home for more than a year. At least eight Post journalists have recently left, including White House correspondent Ebony Bowden and editor-in-chief Maggie Coughlan.

Recognition…New York Post

Mr. Poole, who refused to be interviewed, worked for The Daily Mail from 2003 to 2016, spending part of that time in New York as the chief editor of the US website DailyMail.com. Within two years of working for Mr. Murdoch at The Sun, he had made his website the UK’s largest online brand. Last year he was appointed deputy editor-in-chief.

In a 2018 interview, Mr Poole said he focused on five key areas: news, celebrity, football, money, and women’s lifestyle. While at The Sun, he met frequently with Robert Thomson, the executive director of Mr. Murdoch’s newspaper company News Corp, who was often in the London office before the pandemic, said three people with knowledge of the relationship.

Under Mr. Allan, The Post specialized in celebrity news and coverage in the city, but also championed former President Donald J. Trump and attacked his rivals. Under Mr. Poole, the newspaper continued to focus on celebs and liberal villains, the April 16 front page suggested. The left side showed Jennifer Lopez in a revealing costume under the heading “Inside J-Rod’s Breakup”. On the right a headline blew the Democrats: “PACK RATS. Backlash as Dems attempt to take over the Supreme Court. “

Categories
Health

A brand new research hints at a purpose the J.&J. and AstraZeneca vaccines could trigger blood clots in uncommon circumstances.

A new study hints at a reason the J.&J. and AstraZeneca vaccines may cause blood clots in rare cases.

An advisory group from the Centers for Disease Control and Prevention has recommended that the Johnson & Johnson Covid-19 vaccine hiatus be lifted for all adults while also putting up a warning sign about a rare but dangerous blood clot disorder. However, a central mystery remains: how could a vaccine given to nearly eight million people cause the side effect in just a few of them?

There’s no clear answer yet, but Dr. Andreas Greinacher, a researcher at the University Medical Center Greifswald in Germany, leads an attempt to find out. Speaking at a news conference on Tuesday, he said he had an agreement with Johnson & Johnson to study the components of the vaccine to see if it could interfere with normal blood clotting under certain rare conditions.

“We just agreed that we’d like to work together,” he said.

It is possible, said Dr. Greinacher that the Johnson & Johnson vaccine can cause rare side effects through the same process that he suspects is responsible for similar side effects of the AstraZeneca vaccine. The main component of both vaccines are harmless viruses called adenoviruses, which invade human cells and deliver a coronavirus gene that later triggers an immune response.

On Tuesday, Dr. Greinacher and his colleagues published a report on how the AstraZeneca vaccines can trigger the side effect. The study has not yet been published in a scientific journal.

The scientists found that components of the AstraZeneca vaccine can adhere to a protein that releases platelets when blood clots form. These lumps of molecules could be viewed by the body as foreign invaders, the scientists speculated, triggering a cascade of reactions that turn platelets into dangerous clots.

Dr. Paul A. Offit, a vaccines expert at Philadelphia Children’s Hospital who was not involved in the study, found Dr. Greinacher fascinating, but far from the final word. “It throws a lot of opportunities,” he said.

Dr. Offit said it was not clear which of the many factors the researchers looked at could explain the rare blood clots in people vaccinated with AstraZeneca’s doses. “It’s like taking a sip from a fire hose,” he said.

At a press conference on Tuesday, Dr. Greinacher said the research could reveal ways the AstraZeneca vaccine can lower the risk of blood clots or treat the side effects. However, he stressed that the small risk of these side effects was outweighed by the protection that vaccines like AstraZeneca offer against Covid-19.

“Not being vaccinated is far more dangerous than being vaccinated and at risk for this adverse drug reaction,” he said.

Categories
Business

U.S. ends beneficial pause on use

U.S. ends recommended pause on use

Licensed Professional Nurse Denise Saldana prepares a one-time dose of the Johnson & Johnson COVID-19 vaccine at a clinic aimed at members of the immigrant community on March 25, 2021 in Los Angeles, California.

Mario Tama | Getty Images

U.S. health officials lifted a recommended hiatus from using Johnson & Johnson’s Covid-19 vaccine and gave state and local authorities assistance in distributing the doses that are seen as critical to admitting life-saving shots to hard-to-reach communities bring.

The U.S. regulators’ announcement came after the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, known as ACIP, recommended continued use of the J&J vaccine on Friday, saying that the benefits of the shot had the Risk outweighed. The committee is an external body of experts that advises the CDC.

Advisory panel members did not recommend U.S. regulators limit the use of the J&J vaccine by age or gender, but suggested that the Food and Drug Administration consider adding a warning to women under the age of 50.

J & J’s Covid-19 vaccine, like the Pfizer and Moderna shots, received emergency approval from the FDA to begin distributing the doses in the United States. An EEA grants conditional clearance based on two months of safety data until another submission for full approval, which normally requires at least six months of data.

On April 13, the FDA and CDC urged states to temporarily discontinue use of J & J’s vaccine “out of caution” after it was reported that six women aged 18 to 48 years had a cerebral combination with low platelets Venous sinus thrombosis developed. CVST occurs when a blood clot forms in the venous sinuses of the brain. It can prevent blood from draining from the brain and can eventually lead to bleeding and other brain damage.

Within hours of the warning from U.S. regulators, more than a dozen states, along with some national pharmacies, stopped vaccinating with J & J’s vaccine. Some sites replaced the J&J recordings for scheduled appointments with either the Pfizer or Moderna vaccine.

The US government should lift the recommended hiatus shortly after the committee voted in favor.

Prior to Friday’s vote, the committee debated whether to recommend against J & J’s use of the vaccine or recommend it to U.S. regulators enforcing a warning label. The committee also considered limiting use of the vaccine based on age or other risk factors.

During the meeting, CDC official Dr. Tom Shimabukuro, there have been no reports of the condition of those who received the Pfizer BioNTech mRNA vaccine. There have been three reports of CVST in patients receiving the Moderna vaccine, he said, even though the patients did not have the low platelet levels seen in the J&J recipients.

Platelets help the body form blood clots to heal wounds. US health officials warned against a treatment such as blood-thinning heparin in patients with low platelets, which could make their condition worse.

Rare blood clots with low platelets occur in women aged 18 to 49 at the rate of 7 per 1 million vaccinations for the J&J shot and 0.9 per 1 million in women aged 50 and over. This is evident from a slide presented at the CDC panel meeting. CDC has confirmed a total of 15 cases of rare blood clots, including 12 women who developed blood clots in the brain. According to the presentation, three women died and seven remained in the hospital.

There are no confirmed cases in men, although officials have stated that they are looking at potential additional cases.

Dr. Michael Streiff, a hematologist at Johns Hopkins University Medical School, said the condition is very rare under normal circumstances. “I can tell you from my experience treating these patients that I’ve just never seen it before,” he told the committee during a presentation on Friday.

Earlier this week, J&J announced that it would restart its vaccine rollout in Europe after regulators there backed the single vaccine by recommending adding a warning to the label. The European Medicines Agency has examined all available evidence, including reports from the United States.

This is a developing story. Please try again.

Categories
World News

S&P 500 rebounds greater than 1%, ends the risky week flat

S&P 500 rebounds more than 1%, ends the volatile week flat

US stocks rebounded on Friday as Wall Street reevaluated concerns raised by news that the White House might seek a capital gains tax hike.

The Dow Jones Industrial Average rose 227.59 points, or 0.7%, to 34,043.49 as Goldman Sachs and JPMorgan stocks rose 227.59 points, or 0.7%. The S&P 500 rose 1.1% to 4,180.17, led by Financials and Materials, while the tech-heavy Nasdaq Composite rose 1.4% to 14,016.81.

The S&P 500 ended a turbulent week down just 0.1%, while the Dow and Nasdaq fell 0.5% and 0.3%, respectively, over the course of the week.

Wall Street had a tumultuous meeting for stocks after several news outlets reported Thursday afternoon that President Joe Biden is expected to propose much higher capital gains taxes for the rich.

Bloomberg News reported that Biden plans to increase capital gains tax up to 43.4% for wealthy Americans.

The proposal would increase the capital gains rate for those earning $ 1 million or more from the current 20% to 39.6%, Bloomberg News said, citing people familiar with the matter. Reuters and the New York Times later also reported similar stories.

However, given tight Democratic majority control in Congress, such tax legislation could face challenges, and many on Wall Street believe a less dramatic increase is more likely.

“We expect Congress to pass a scaled-down version of this tax hike,” Goldman Sachs economists wrote in a note. “We expect Congress to agree on a more modest increase, possibly 28%.”

Meanwhile, US taxable domestic investors own only about 25% of the US stock market, according to UBS. The rest of the market is in accounts that are not subject to capital gains tax, such as B. Retirement accounts, foundations and foreign investors. Therefore, even with a higher tax rate, the impact on overall stock prices should be limited.

“We would expect opportunistic investors who are not affected by this proposal to step in and benefit from lower prices,” said UBS strategists in a statement on Friday.

Intel stock fell more than 5% after it released an earnings forecast in the second quarter that fell below analysts’ hopes. American Express fell over 4% after the credit card company reported quarterly revenue that fell slightly short of forecast.

Snap stock, meanwhile, rose 7.5% after the company posted accelerated revenue growth and strong user numbers in the first quarter. Snap broke even on balance with sales of $ 770 million.

Companies so far have largely managed to beat Wall Street’s predictions for the earnings season. Even so, strong first quarter results have been met with a tepid reaction from investors who have not yet bought shares in companies with some of the best performing.

Strategists say that already high ratings and near record highs for the S&P 500 and Dow have kept traders’ excitement in check. However, the indices are within 1% of their all-time high.

Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to start a free trial today

Categories
Health

CDC panel recommends resuming use

CDC panel recommends resuming use

An advisory panel to the Centers for Disease Control and Prevention on Friday recommended the US resume vaccine from Johnson and Johnson Covid-19, with the benefits outweighing the risk.

Panel members did not recommend U.S. regulators limit use of the vaccine based on age or gender, but suggested that the FDA consider adding a warning to women under the age of 50.

The recommendation, accepted 10: 4 with one abstention by the CDC Advisory Committee on Immunization Practices, will pave the way for US regulators to end their recommended break in the use of the J&J shot earlier this weekend.

The single shot is an important tool for delivering life-saving vaccines to hard-to-reach places where reliable cooling may not be available, e.g. A second dose is given in tribal, poorer areas, and rural communities, and for people who may not be able to return, US health officials say.

The committee, an external panel of experts advising the CDC, decided last week to postpone a decision on the vaccine while officials continued to study cases of six women aged 18 to 48 who had combined cerebral venous sinus thrombosis (CVST ) developed with low platelets within about two weeks of receiving the shot.

The Food and Drug Administration and CDC on April 13 urged states to temporarily suspend use of J & J’s vaccine “out of caution” following reports of the rare blood clots. Within hours of the alert, more than a dozen states, as well as a few national pharmacies, suspended vaccinations with J & J’s vaccine, with some replacing scheduled appointments with either the Pfizer or Moderna vaccine.

Prior to Friday’s vote, the committee debated whether to recommend against J & J’s use of the vaccine or recommend it to U.S. regulators enforcing a warning label. The committee also considered limiting use of the vaccine based on age or other risk factors.

CVST occurs when a blood clot forms in the venous sinuses of the brain. It can prevent blood from draining from the brain and can eventually lead to bleeding and other brain damage. The blood clots are similar to those reported in some people who received the Covid-19 vaccine from AstraZeneca.

During the meeting on Friday, Dr. Tom Shimabukuro, a CDC official, said there have been no reports of the condition of those who received the Pfizer BioNTech mRNA vaccine. There have been three reports of CVST in patients receiving the Moderna vaccine, he said, even though the patients did not have the low platelet levels seen in the J&J recipients.

Platelets help the body form blood clots to heal wounds. US health officials warned against a treatment such as blood-thinning heparin in patients with low platelets, which could make their condition worse.

Rare blood clots with low platelets occur in women aged 18 to 49 at the rate of 7 per 1 million vaccinations for the J&J shot and 0.9 per 1 million in women aged 50 and over. This is evident from a slide presented at the CDC panel meeting. CDC has confirmed a total of 15 cases of rare blood clots, including 12 women who developed blood clots in the brain. Three women have died and seven remained in the hospital, according to slides.

There are no confirmed cases in men, although officials have stated that they are looking at potential additional cases.

Dr. Michael Streiff, a hematologist at Johns Hopkins University Medical School, said the condition is very rare under normal circumstances. “I can tell you from my experience treating these patients that I’ve just never seen it before,” he told the committee during a presentation on Friday.

A CDC model presented at the meeting showed that not resuming use of J & J’s vaccine would delay immunization for all adults who wish to receive the shots by 14 days.

J&J executives told the committee that the vaccine’s benefits still outweighed the risks, adding that the shots would prevent death and hospitalizations. They proposed a new warning label for the vaccine explaining the risk of blood clots.

“We could expect that if 1 million people in the US were vaccinated with the J&J single-dose vaccine, there would be more than 2,000 deaths and 6,000 fewer hospital stays associated with Covid,” said Dr. Joanne Waldstreicher, Chief Medical Officer of J & J.

Earlier this week, J&J announced that it would restart its vaccine rollout in Europe after regulators there backed the single vaccine by recommending adding a warning to the label. The European Medicines Agency has examined all available evidence, including reports from the United States.

Last week, US health officials announced that the hiatus from using the vaccine would only be a few days, depending on what they learned from investigating the cases

Before the CDC meeting, Dr. Wilbur Chen, a member of the committee, told CNBC that he saw “a great amount of evidence” that the benefits of the J&J vaccine still outweighed its risks.

“I think we are ready to use this vaccine. We had to take an important pause to review this safety information in order to consider the risks. But I think there is a great amount of evidence of this to be of benefit that risk far outweighs that, “Chen, a professor at the University of Maryland Medical School, told Worldwide Exchange.

This is a developing story. Please try again.

Categories
Politics

Trump Backs New Group for Conservative Donors

Trump Backs New Group for Conservative Donors

Former President Donald J. Trump supports a group whose officials say it will aim to fight the sprawling democratic donor network, the Democracy Alliance. This is Trump’s most recent attempt to shape and campaign for Republican fundraisers since leaving the White House.

The group, known as the America Alliance, will urge donors to make annual dues and commit to giving $ 100,000 to candidates and organizations recommended by the umbrella group. This is evident from internal documents and people who are familiar with the plans. Mr Trump has asked Michael Glassner, the former chief operating officer of the 2020 Trump re-election campaign, to become the chief executive officer.

The new group will recommend making contributions to companies founded or partnered with Trump allies, as well as organizations affiliated with Mr. Trump, including a proposed Super PAC and his own multi-candidate PAC.

Internal documents for the group, reviewed by the New York Times, contain a notice that No. Employees “are paid on a commission basis.”

Mr Trump said in a statement to the Times that the group – as well as its own candidate committees and party committees – was a way to gain a foothold against Democrats.

“Republicans have been at a fundraising disadvantage for years, but now we’re going to beat the Democrats at their own game thanks to Save America, Make America Great Again PAC, the America Alliance, our fine party committees, and all of our other support groups,” said Mr. Trump.

The group was originally conceived by Caroline Wren, a professional fundraiser who worked for officials like Senator Lindsey Graham of South Carolina and worked on the former president’s re-election campaign. When it was first given to donors weeks ago, some aides to Mr Trump said he was dissatisfied with its existence because it competed with other groups he supported and that he hadn’t signed it. Since then, he has become aware of the idea of ​​a new group that, according to official information, will focus on grassroots activities and donations to other organizations.

Mr. Trump decided to install Mr. Glassner at the top of the structure, with Ms. Wren working for Mr. Glassner as a senior advisor along with a number of other senior executives and a board of directors of a dozen advisors.

Ms. Wren has told strategists that she has met more than 100 donors in the past five months and has repeatedly heard a wish that these types of businesses can channel money more effectively.

Mr Trump’s move comes as the Republican donor class enters an intermediate and new presidential cycle in which the Republican National Committee, Congressional committees, and individual candidate committees vie for donor support.

Mr. Trump’s Political Action Committee, Save America, has nearly $ 90 million in store, raised mostly in the weeks following the November 3 elections, which he falsely claimed were stolen from him. The former president has repeatedly drawn lots for fundraisers at his private club, Mar-a-Lago, for candidates seeking his support.